Partners4Access

Weekly Roundup: October 11, 2018

Weekly Roundup: October 11, 2018

The P4A team analyze Novartis' deal with Celluar Biomedicine Group to supply the CAR-T therapy Kymriah and the successes and failures of the reimbursement of Vertex's cystic fibrosis drug, Orkambi. Presenter: Max Rex Contributor: Nader Murad, Senior Analyst

Duration: 8 min

Release Date:

Share part or all of the audio of this episode